Molecular laboratory testing for tuberculosis: innovators, early adopters, or laggards?
Clin Infect Dis
.
2014 Apr;58(7):977-9.
doi: 10.1093/cid/ciu024.
Epub 2014 Jan 14.
Author
Max Salfinger
1
Affiliation
1
Department of Medicine, National Jewish Health, Denver, Colorado.
PMID:
24429435
DOI:
10.1093/cid/ciu024
No abstract available
Keywords:
Mycobacterium tuberculosis; NAAT; Xpert; drug resistance; tuberculosis.
Publication types
Editorial
Comment
MeSH terms
Female
Humans
Male
Tuberculosis / diagnosis*